How mRNA Could Sharpen Flu Protection: Professor Corbett-Helaire in GBH News
How mRNA Could Sharpen Flu Protection: Professor Corbett-Helaire in GBH News
By
Lucia Ricci
August 10, 2026
Professor Kizzmekia S. Corbett-Helaire was featured in GBH News discussing Moderna’s newly approved mRNA flu vaccine and how the technology may improve influenza protection. She explains that mRNA technology presents flu proteins to the immune system with greater precision—like a high-definition image—helping the body more clearly recognize what it needs to fight.
Read the full story and her insights.
About The Author
Lucia Ricci
Related Topics
Last Updated
Related News
-
Extreme heat: Who’s most at risk and ways to stay safe
Environment & Climate Health August 7, 2026 -
Eric Neubauer Vickers (G4, Grad Lab)
August 7, 2026 -
Madeline Farringer (G5, Dvorin Lab and Wirth Lab)
August 7, 2026
Get the latest public health news
Stay connected with Harvard Chan School
Unleash your potential at Harvard Chan School.
In addition to our degree programs, we offer highly targeted programs through our Advanced Learning Academy, directed and taught by Harvard faculty.
点赞
收藏
点踩
分享评论
?
参与讨论